Who
Richard Marshak
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, TriSalus Life Sciences.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $67K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Aug 2023
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 May 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $1,427325 at $4.39 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | $2,171561 at $3.87 | filing |
| 30 Jun 2026filed 1 Jul 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | $2,171561 at $3.87 | filing |
| 15 May 2026filed 19 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $1,450543 at $2.67 | filing |
| 15 May 2026filed 19 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $1,450543 at $2.67 | filing |
| 16 Mar 2026filed 20 Mar 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $1,726419 at $4.12 | filing |
| 16 Mar 2026filed 20 Mar 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $1,726419 at $4.12 | filing |
| 12 Mar 2026filed 20 Mar 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $6,4991,589 at $4.09 | filing |
| 12 Mar 2026filed 20 Mar 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $6,4991,589 at $4.09 | filing |
| 11 Mar 2026filed 20 Mar 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $5,9841,449 at $4.13 | filing |
| 11 Mar 2026filed 20 Mar 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $5,9841,449 at $4.13 | filing |
| 31 Dec 2025filed 1 Jul 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | $1,967449 at $4.38 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 30 Jun 2025filed 1 Jul 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | $3,934930 at $4.23 | filing |
| 19 May 2025filed 21 May 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | $111K21,428 at $5.18 | filing |
| 19 May 2025filed 21 May 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Sold | $34K6,597 at $5.18 | filing |
| 18 Feb 2025filed 19 Feb 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —7,644 at $0.00 | filing |
| 27 Jan 2025filed 29 Jan 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 27 Jan 2025filed 29 Jan 2025 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
News
Financial Comparison: Brainsway (NASDAQ:BWAY) and TriSalus Life Sciences (NASDAQ:TLSI)TLSI · dailypolitical.com · 14 Oct 2026TriSalus Life Sciences, Inc. (TLSI) – What Are Brokerages Saying About This Stock?TLSI · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Richard Marshak; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.